S. Nicole Schaeffer Orlov Net Worth & Insider Trades
S. Nicole Schaeffer Orlov - SVP, Amicus Therapeutics Inc
What is S. Nicole Schaeffer Orlov's Net Worth?
The current estimated net worth of Amicus Therapeutics Inc's SVP, S. Nicole Schaeffer Orlov, is estimated to be about $5.28M . S. Nicole Schaeffer Orlov owns about 12,582 units of Amicus Therapeutics Inc common stock. In the last 4 years at Amicus Therapeutics Inc, S. Nicole Schaeffer Orlov has sold an estimated value of $3.83K worth.
What is S. Nicole Schaeffer Orlov's Past Insider Trading?
S. Nicole Schaeffer Orlov's largest sale order was 213 units , worth over $3.83K on August 14, 2008. In total, S. Nicole Schaeffer Orlov has made about 9 transactions over 4 years of their time at Amicus Therapeutics Inc. S. Nicole Schaeffer Orlov usually trades in February, with the busiest year in 2008.
S. Nicole Schaeffer Orlov
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What was S. Nicole Schaeffer Orlov's Salary in 2020?
As SVP of Amicus Therapeutics Inc, S. Nicole Schaeffer Orlov has a total base salary of $452, . S. Nicole Schaeffer Orlov received compensation valued at about $2,885,820 in 2020 after becoming SVP. The vast majority of their compensation came in the form of a bonus of $199,051 , stock awards of $1,461,322 , other earnings, plans or compensations of $664,660 , change in pension value of $87,751 , and other compensation of $20,748 .
What is S. Nicole Schaeffer Orlov's' Mailing Address?
- Mailing address is Insmed Incorporated 10 Finderne Avenue Bridgewater NJ 08807 NJ
Amicus Therapeutics Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Other Earnings Plans or Compensations
|
Change in Pension Value
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| John F. Crowley | 2020 | $719,514 | $514,800 | $5,479,971 | $2,492,491 | $1,282,843 | $825,505 | $11,315,124 |
| John F. Crowley | 2019 | $656,770 | $476,815 | $5,327,948 | $2,334,850 | $234,775 | $821,505 | $9,852,663 |
| John F. Crowley | 2018 | $637,640 | $445,710 | $3,861,699 | $1,654,347 | - | $820,567 | $7,419,963 |
| Daphne Quimi | 2020 | $45 | $228,712 | $1,534,382 | $697,894 | - | $34,639 | $2,947, |
| Daphne Quimi | 2019 | $400,000 | $212,960 | $1,311,492 | $538,808 | - | $17,487 | $2,480,747 |
| Daphne Quimi | 2018 | - | - | - | - | - | - | - |
| Bradley L. Campbell | 2020 | $515, | $368,872 | $2,557,304 | $1,163,159 | - | $33,694 | $4, |
| Bradley L. Campbell | 2019 | $500,877 | $378,788 | $2,254,114 | $987,822 | - | $19,538 | $4,141,139 |
| Bradley L. Campbell | 2018 | $468,109 | $327,209 | $1,411,802 | $604,817 | - | $16,710 | $2,828,646 |
| Hung Do | 2020 | $42 | $187,908 | $1,461,322 | $664,660 | - | $31,248 | $2,772,106 |
| Hung Do | 2019 | $414,625 | $200,678 | $1,393,462 | $574,732 | - | $22,129 | $2,605,626 |
| Hung Do | 2018 | - | - | - | - | - | - | - |
| Ellen S. Rosenberg | 2020 | $452, | $199,051 | $1,461,322 | $664,660 | $87,751 | $20,748 | $2,885,820 |
| Ellen S. Rosenberg | 2019 | $439,213 | $233,837 | $1,393,462 | $610,648 | - | $13,538 | $2,690,698 |
| Ellen S. Rosenberg | 2018 | $426,420 | $208,647 | $996,591 | $426,933 | - | $18,270 | $2,076,862 |
| Jay Barth | 2020 | $366,269 | - | $1,315,184 | $598,197 | - | $641,306 | $2,920,956 |
| Jay Barth | 2019 | $471,621 | $228,265 | $1,229,522 | $538,808 | - | $15,998 | $2,484,214 |
| Jay Barth | 2018 | $457,885 | $192,037 | $996,591 | $426,933 | - | $18,790 | $2,092,236 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1178879/000114036121014545/nc10021408x1_def14a.htm
What are Amicus Therapeutics Inc's Past Insider Trades?
Amicus Therapeutics Inc's most recent insider trade came on March 17, 2023 by John Crowley who sold 6,044 units worth $68.55K . In the last 16 years, insiders at Amicus Therapeutics Inc have sold an estimated value of $186.71M and bought an estimated value of $193.09M worth of shares. Insider trading is most common in June, with the busiest year in 2008. The most active traders at the company are John Crowley, Executive Chairman, Bradley Campbell, President & CEO, and Daphne Quimi, Chief Financial Officer .
AMICUS THERAPEUTICS, INC. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||